Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG.

Ivens IA, Banczyk D, Gutberlet K, Jackman S, Vauléon S, Frisk AL.

Toxicol Pathol. 2019 Jul;47(5):585-597. doi: 10.1177/0192623319852300. Epub 2019 May 27.

PMID:
31132933
2.

Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.

Schmid E, Klotz M, Steiner-Hahn K, Konen T, Frisk AL, Schatz C, Krahn T, von Ahsen O.

Biotech Histochem. 2017;92(6):425-435. doi: 10.1080/10520295.2017.1339913. Epub 2017 Aug 24.

PMID:
28836864
3.

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.

Lohrke J, Frisk AL, Frenzel T, Schöckel L, Rosenbruch M, Jost G, Lenhard DC, Sieber MA, Nischwitz V, Küppers A, Pietsch H.

Invest Radiol. 2017 Jun;52(6):324-333. doi: 10.1097/RLI.0000000000000344.

4.

Resonant x-ray diffraction revealing chemical disorder in sputtered L10 FeNi on Si(0 0 1).

Frisk A, Lindgren B, Pappas SD, Johansson E, Andersson G.

J Phys Condens Matter. 2016 Oct 12;28(40):406002. doi: 10.1088/0953-8984/28/40/406002. Epub 2016 Aug 12.

PMID:
27518923
5.

Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity.

Wengner AM, Siemeister G, Koppitz M, Schulze V, Kosemund D, Klar U, Stoeckigt D, Neuhaus R, Lienau P, Bader B, Prechtl S, Raschke M, Frisk AL, von Ahsen O, Michels M, Kreft B, von Nussbaum F, Brands M, Mumberg D, Ziegelbauer K.

Mol Cancer Ther. 2016 Apr;15(4):583-92. doi: 10.1158/1535-7163.MCT-15-0500. Epub 2016 Feb 1.

6.

Glomerulonephritis-induced changes in kidney gene expression in rats.

Pavkovic M, Riefke B, Frisk AL, Gröticke I, Ellinger-Ziegelbauer H.

Genom Data. 2015 Aug 18;6:81-2. doi: 10.1016/j.gdata.2015.08.021. eCollection 2015 Dec.

7.

Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease.

Fritsch M, Schmidt N, Gröticke I, Frisk AL, Keator CS, Koch M, Slayden OD.

PLoS One. 2015 Nov 20;10(11):e0142429. doi: 10.1371/journal.pone.0142429. eCollection 2015.

8.

Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in Rats.

Pavkovic M, Riefke B, Frisk AL, Gröticke I, Ellinger-Ziegelbauer H.

Toxicol Sci. 2015 Jun;145(2):348-59. doi: 10.1093/toxsci/kfv053. Epub 2015 Mar 9.

PMID:
25758243
9.

Expression analysis of the Pseudomonas aeruginosa AlgZR two-component regulatory system.

Pritchett CL, Little AS, Okkotsu Y, Frisk A, Cody WL, Covey CR, Schurr MJ.

J Bacteriol. 2015 Feb 15;197(4):736-48. doi: 10.1128/JB.02290-14. Epub 2014 Dec 8.

10.

Comparison of progestin transcriptional profiles in rat mammary gland using Laser Capture Microdissection and whole tissue-sampling.

Mazurek N, Frisk AL, Beekman JM, Hartwig A, Meyer K.

Exp Toxicol Pathol. 2013 Nov;65(7-8):949-60. doi: 10.1016/j.etp.2013.01.009. Epub 2013 Mar 7.

PMID:
23466250
11.

The effect of iodinated contrast agent properties on renal kinetics and oxygenation.

Lenhard DC, Frisk AL, Lengsfeld P, Pietsch H, Jost G.

Invest Radiol. 2013 Apr;48(4):175-82. doi: 10.1097/RLI.0b013e31827b70f9.

PMID:
23262792
12.

D-18F-fluoromethyl tyrosine imaging of bone metastases in a mouse model.

Zitzmann-Kolbe S, Strube A, Frisk AL, Käkönen SM, Tsukada H, Hauff P, Berndorff D, Graham K.

J Nucl Med. 2010 Oct;51(10):1632-6. doi: 10.2967/jnumed.110.078899. Epub 2010 Sep 16.

13.

Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner.

Cody WL, Pritchett CL, Jones AK, Carterson AJ, Jackson D, Frisk A, Wolfgang MC, Schurr MJ.

J Bacteriol. 2009 May;191(9):2993-3002. doi: 10.1128/JB.01156-08. Epub 2009 Mar 6.

14.

Pseudomonas aeruginosa AlgR represses the Rhl quorum-sensing system in a biofilm-specific manner.

Morici LA, Carterson AJ, Wagner VE, Frisk A, Schurr JR, Höner zu Bentrup K, Hassett DJ, Iglewski BH, Sauer K, Schurr MJ.

J Bacteriol. 2007 Nov;189(21):7752-64. Epub 2007 Aug 31.

15.

The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa.

Carterson AJ, Morici LA, Jackson DW, Frisk A, Lizewski SE, Jupiter R, Simpson K, Kunz DA, Davis SH, Schurr JR, Hassett DJ, Schurr MJ.

J Bacteriol. 2004 Oct;186(20):6837-44.

16.

Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells.

Frisk A, Schurr JR, Wang G, Bertucci DC, Marrero L, Hwang SH, Hassett DJ, Schurr MJ.

Infect Immun. 2004 Sep;72(9):5433-8.

17.

Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis.

Lizewski SE, Schurr JR, Jackson DW, Frisk A, Carterson AJ, Schurr MJ.

J Bacteriol. 2004 Sep;186(17):5672-84.

18.

Molecular profiling of hepatotoxicity induced by a aminoguanidine carboxylate in the rat: gene expression profiling.

Schuppe-Koistinen I, Frisk AL, Janzon L.

Toxicology. 2002 Oct 15;179(3):197-219.

PMID:
12270593
19.
20.

The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity.

Frisk A, Lebens M, Johansson C, Ahmed H, Svensson L, Ahlman K, Lagergård T.

Microb Pathog. 2001 Jun;30(6):313-24.

PMID:
11399138
23.

Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection.

Gröne A, Frisk AL, Baumgärtner W.

Vet Immunol Immunopathol. 1998 Sep 16;65(1):11-27.

PMID:
9802573
24.

Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.

Frisk A, Ahmed HJ, Van Dyck E, Lagergård T.

Microb Pathog. 1998 Aug;25(2):67-75.

PMID:
9712686
25.
26.
27.

Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody.

Purvén M, Frisk A, Lönnroth I, Lagergard T.

Infect Immun. 1997 Aug;65(8):3496-9.

28.

Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.

Ahmed HJ, Frisk A, Månsson JE, Schweda EK, Lagergård T.

Infect Immun. 1997 Aug;65(8):3151-8.

29.

Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.

Lagergård T, Frisk A, Trollfors B.

J Antimicrob Chemother. 1996 Nov;38(5):849-52.

PMID:
8961054
30.

Localisation and immunological properties of a 24-kDa surface protein of Haemophilus ducreyi.

Frisk A, Roggen EL, Lagergård T.

J Med Microbiol. 1995 Sep;43(3):192-200.

PMID:
7650727
31.

Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.

Lagergård T, Frisk A, Purvèn M, Nilsson LA.

Microb Pathog. 1995 Jan;18(1):37-51.

PMID:
7783597
32.

Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells.

Lagergård T, Purvén M, Frisk A.

Microb Pathog. 1993 Jun;14(6):417-31.

PMID:
8412616
33.

Lymphocyte stimulation in Candida albicans infections.

Frisk A, von Stedingk LV, Wasserman J.

Sabouraudia. 1974 Mar;12(1):87-94. No abstract available.

PMID:
4210102
34.

Successful treatment of Candida septicaemia in severely burned patients with a new antimycotic, clotrimazole (Bay b 5097).

Liljedahl SO, Frisk A, Wickman K.

Injury. 1972 Nov;4(2):157-63. No abstract available.

PMID:
4578796
35.

Effect of oxyphenbutazone on concentration of penicillin in serum.

Frisk AR, Tunevall G.

Experientia. 1972 Mar 15;28(3):296-7. No abstract available.

PMID:
5026440
36.

Finger-sucking in children. A study of incidence and occlusal conditions.

Baalack IB, Frisk AK.

Acta Odontol Scand. 1971 Nov;29(5):499-512. No abstract available.

PMID:
5290977
37.

Lymphocyte stimulation with Candida albicans antigens.

Frisk A, Wasserman J.

Antonie Van Leeuwenhoek. 1969 Jun;35:E13. No abstract available.

PMID:
5312051
38.

[The width of teeth and dental arch in relation to the fluoride content of drinking water].

Baalack IB, Frisk AK.

Sven Tandlak Tidskr. 1969 Apr;62(4):259-74. Swedish. No abstract available.

PMID:
5267057
39.

[Side-effects and occurrence of yeast-like fungi in patients on oral treatment with tetracycline-nystatin].

Bjurwill B, Frisk A.

Nord Med. 1968 Dec 12;80(50):1695-8. Norwegian. No abstract available.

PMID:
4906210
40.

[Instruction of a diabetes patient from the nurse's viewpoint].

Frisk A.

Sairaanhoitaja. 1968 Nov 25;44(17):774-5. Finnish. No abstract available.

PMID:
5190339
41.

[Fingersucking in 12-year-olds as a psychological problem].

Baalack IB, Frisk AK.

Sven Tandlak Tidskr. 1968 Apr;61(4):233-42. Swedish. No abstract available.

PMID:
5248954
42.

Clinical evaluation of minocycline.

Frisk AR, Tunevall G.

Antimicrob Agents Chemother (Bethesda). 1968;8:335-9. No abstract available.

PMID:
5735378
43.

Potassium-6 (D-alpha-azidophenyl-acetamido)-penicillinate, a new penicillin.

Tunevall G, Frisk AR.

Acta Pathol Microbiol Scand. 1968;72(3):462. No abstract available.

PMID:
5301225
44.

[Sulfasymazine--a new sulfa derivative].

Frisk AR, Hultman E.

Lakartidningen. 1966 Jun 29;63(26):2519-23. Swedish. No abstract available.

PMID:
5919120
45.

Epidemic occurrence of trichophytosis among wrestlers.

Frisk A, Heilborn H, Melén B.

Acta Derm Venereol. 1966;46(5):453-6. No abstract available.

PMID:
4162948
46.

Sulfasymazine.

Frisk AR, Hultman E.

Antimicrob Agents Chemother (Bethesda). 1965;5:672-6. No abstract available.

PMID:
5327525
47.

[MISTREATED SMALL CHILDREN].

FRISK A.

Sven Lakartidn. 1964 Oct 7;61:3004-12. Swedish. No abstract available.

PMID:
14245817
48.

AETIOLOGIC AGENTS IN RESPIRATORY ILLNESS. OCCURRENCE OF BACTERIA AND SEROLOGIC REACTIONS AGAINST VIRUSES AND BACTERIA IN ACUTE RESPIRATORY ILLNESS.

TUNEVALL G, OHLSON M, SUEDMYR A, VONZEIPEL G, FRISK A, HEDLUND P, LAMBERGER B, JERNELIUS H.

Acta Med Scand. 1963 Aug;174:237-48. No abstract available.

PMID:
14051142
49.

IN VITRO ACTIVITY AND BLOOD CONCENTRATION STUDIES WITH A SERIES OF PHENOXYALKYLPENICILLINS.

FRISK AR, TUNEVALL G.

Chemotherapia (Basel). 1963;33:67-76. No abstract available.

PMID:
14059437
50.

[A new antimycotic preparation for dermatological use].

NORMAN A, FRISK A.

Sven Lakartidn. 1961 Oct 13;58:2922-4. Swedish. No abstract available.

PMID:
14480345

Supplemental Content

Support Center